Monthly Archives: October 2025
New ADA Guidelines Signal Shift in Early Combination Therapy for Type 2 Diabetes
Explore the new ADA guidelines advocating early combination therapy for Type 2 diabetes, aiming for improved patient outcomes and personalized care.
From Open Rates to Outcomes: Rethinking Pharma Email Marketing Strategy
Rethink pharma email marketing by focusing on outcomes, not just open rates, to boost engagement with healthcare professionals and patients.
Why Podiatry Should Be a First-Line Strategy in Diabetes Management
Discover why integrating podiatry into diabetes care is essential for preventing complications and enhancing patient well-being.
AI-Powered Personalization: Redefining Pharma’s Digital Marketing Strategy
Explore how AI-powered personalization is transforming pharma's digital marketing strategy, enhancing customer experience, and boosting campaign efficiency.
Cardiovascular Outcomes in Diabetes: New Evidence From 2025 Trials
Discover groundbreaking 2025 trials reshaping cardiovascular outcomes in diabetes, highlighting new therapies and holistic care strategies.
How GLP-1 Drugs Like Ozempic and Mounjaro Are Redefining Diabetes Care
Discover how GLP-1 drugs like Ozempic and Mounjaro are transforming diabetes care by enhancing glycemic control and reducing cardiovascular risks.
Omnichannel Pharma Marketing: Redefining HCP Engagement in the Post-Rep Era
Explore how omnichannel pharma marketing is transforming HCP engagement, blending digital and traditional methods for effective communication in the post-rep era.